23.Effect on Mobility and Pain with Collagen Peptides in Knee Osteoarthritis in Pakistani Population
Mehwish Mansoor1, Muhammad Ali Zubair1, Shabih Zehra3, Muhammad Sajid Abbas Jaffri2, Hina Amjad1 and Syed Ijaz Hussain Zaidi1
ABSTRACT
Objective: To evaluate the effects on mobility and pain with the use of collagen active peptides in knee osteoarthritis patients in Pakistani Population.
Study Design: It is an open label randomized clinical trial study.
Place and Duration of Study: This study was conducted at the Tertiary Care Hospital, Karachi from Sep, 2020 to March, 2021 for a period of six months.
Materials and Methods: One hundred and ten patients were scheduled in the study suffering from knee osteoarthritis. They were divided into three groups; Group I Diacerein (n=37), Group II Collagen active peptides (n=37) and Group III NSAID’s (Diclofenac Potassium) (n=36).
Results: One hundred and two patients successfully completed the study with collagen active peptides improving the intensity of pain (VAS) visual analogue score at 6th and 12th weeks (p > 0.001) with highly significant results.
Conclusion: Collagen active peptides not only reduces pain and associated joint stiffness with OA but also enhances the functional mobility hence the quality of life improved with the use of collagen active peptides.
Key Words: Collagen active peptides, mobility, visual analogue score
Citation of article: Mansoor M, Zubair MA, Zehra S, Jaffri MSA, Amjad H, Zaidi SIH. Effect on Mobility and pain with Collagen Peptides in Knee Osteoarthritis in Pakistani Population. Med Forum 2021;32(10):103-107.